课题基金 / 基金详情

General Clinical Research Center

General Clinical Research Center
全科临床研究中心
批准号:
7045941
负责人:
Nicholas Chiorazzi
金额:
$294.35万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-07-01 至 2008-03-31

项目摘要

项目成果

Nicholas Chiorazzi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
EXCEED THE SPACE PROVIDED. The North Shore-LIJ Research Institute is applying for NCRR support of the North Shore-LIJ GCRC. The clinical and biomedical research mission of the North Shore-LIJ Research Institute is closely allied with the academic medical canters at North Shore University Hospital and Long Island Jewish Medical Center. The volume of NIH- funded patient-oriented research conducted within the North Shore-LIJ Research Institute is significant by any measure. North Shore-LIJ combined now ranks 16th nationwide for independent hospitals receiving NIH funding. North Shore-LIJ IRBs currently oversee more than 1200 active clinical research protocols annually; this includes more than 200 investigator-initiated protocols involving human subjects. The quality and quantity of clinical research conducted at North Shore-LIJ has a reached critical mass that requires the expansion and strengthening of the institutional capabilities and infrastructure to sustain high quality clinical research. In late 2001 the North Shore-LIJ Research Institute built an outpatient GCRC to centralize these critically important clinical research elements. The North Shore-LIJ GCRC is fully operational; an inpatient GCRC is scheduled to open in November 2002 on the campus of North Shore University Hospital. Clinical investigators in the North Shore-LIJ GCRC are supported by an expedencad administrative and nursing staff, a Research Subject Advocate, and a GCRC Advisory Committee that has been meeting since October, 2001. The Interfacility Transport Division provides transportation of patients from hospital
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Th17 generation, action and therapeutic relevance in chronic lymphocytic leukemia
Th17 generation, action and therapeutic relevance in chronic lymphocytic leukemia
Th17 generation, action and therapeutic relevance in chronic lymphocytic leukemia
Th17 generation, action and therapeutic relevance in chronic lymphocytic leukemia
海外基金